Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Red Blood Cell Disorder (Disorder)”

105 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 105 results

Not applicableStudy completedNCT05506358
What this trial is testing

Evaluation of Low-cost Techniques for Detecting Sickle Cell Disease and β-thalassemia in Nepal and Canada

Who this might be right for
Sickle Cell DiseaseSickle Cell TraitBeta-Thalassemia+2 more
University of British Columbia 145
Testing effectiveness (Phase 2)Study completedNCT05100212
What this trial is testing

UmBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity (BORN)

Who this might be right for
Retinopathy of Prematurity
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 146
Early research (Phase 1)Study completedNCT03126695
What this trial is testing

Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered

Who this might be right for
Sickle Cell Disease
AstraZeneca 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07331818
What this trial is testing

Luspatercept in Patients Affected With Rare Inherited Anemias

Who this might be right for
Hereditary Red Blood Cell Disorder (Disorder)
EuroBloodNet Association 45
Not applicableLooking for participantsNCT06250595
What this trial is testing

European Rare Blood Disorders Platform (ENROL)

Who this might be right for
AnemiaBone Marrow FailureBleeding Disorder+9 more
Hospital Universitari Vall d'Hebron Research Institute 37,090
Not applicableStudy completedNCT01484886
What this trial is testing

Restrictive Versus Liberal Transfusion Protocol in Infants Undergoing Cardiac Surgery

Who this might be right for
Impaired Oxygen DeliveryCongenital Heart Disease
University of Rochester 162
Testing effectiveness (Phase 2)WithdrawnNCT00850369
What this trial is testing

A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary Hypertension

Who this might be right for
Pulmonary HypertensionSickle Cell Disease
University of North Carolina, Chapel Hill
Not applicableStudy completedNCT02372877
What this trial is testing

Evaluation of the AMICUS RBCx System in Sickle Cell Patients

Who this might be right for
Sickle Cell Anemia
Fenwal, Inc. 83
Not applicableLooking for participantsNCT06944067
What this trial is testing

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
National Human Genome Research Institute (NHGRI) 50
Not applicableEnded earlyNCT00290628
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDiamond-blackfan AnemiaFanconi Anemia+6 more
Masonic Cancer Center, University of Minnesota 43
Not applicableUnknownNCT05282888
What this trial is testing

ERYthrocyte Morphology Using Flow Imaging on ImageSTREAM Cytometer

Who this might be right for
Red Blood CellsSchistocytesArtificial Intelligence
Centre Hospitalier Universitaire, Amiens 200
Testing effectiveness (Phase 2)Study completedNCT03342404
What this trial is testing

Determine the Efficacy and Safety of Luspatercept in Adults With Non Transfusion Dependent Beta (β)-Thalassemia

Who this might be right for
Thalassemia
Celgene 145
Not applicableStudy completedNCT06831799
What this trial is testing

ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

Who this might be right for
HemoglobinopathiesSickle Cell DiseaseSickle Cell Anemia+21 more
Hospital Universitari Vall d'Hebron Research Institute 684
Testing effectiveness (Phase 2)Active Not RecruitingNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Not applicableLooking for participantsNCT04778657
What this trial is testing

National Exhaustive Cohort of Hereditary Stomatocytoses and Other Channelopathies Affecting the Red Blood Cell

Who this might be right for
Stomatocytosis
Assistance Publique - Hôpitaux de Paris 150
Post-approval studies (Phase 4)Study completedNCT03992001
What this trial is testing

Impact of the Preparation Method of Red Cell Concentrates on Transfusion Indices in Thalassemic Patients

Who this might be right for
Thalassemia Major
Università degli Studi di Ferrara 55
Early research (Phase 1)Study completedNCT04426591
What this trial is testing

Red Blood Cell Survival in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Marianne Yee 22
Testing effectiveness (Phase 2)Ended earlyNCT01464164
What this trial is testing

Safety and Efficacy Study of Sotatercept in Adults With Transfusion Dependent Diamond Blackfan Anemia

Who this might be right for
Diamond Blackfan Anemia
Northwell Health 19
Large-scale testing (Phase 3)Looking for participantsNCT06439082
What this trial is testing

Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Who this might be right for
Sickle Cell Disease
Novartis Pharmaceuticals 315
Not applicableLooking for participantsNCT06213402
What this trial is testing

RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)

Who this might be right for
Sickle Cell DiseaseThalassemiaHemolytic; Anemia, Hereditary, Due to Enzyme Disorder+6 more
Hospital Universitari Vall d'Hebron Research Institute 32,564
Load More Results